Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes

doi:10.1371/journal.pone.0115686

Paper

Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes

Published Feb 11, 2015 · Chiara Focaccetti, A. Bruno, E. Magnani

PLoS ONE

Q1 SJR score

246

Citations

5

Influential Citations

Open Access PDF Full text Semantic Scholar

Abstract

Antimetabolites are a class of effective anticancer drugs interfering in essential biochemical processes. 5-Fluorouracil (5-FU) and its prodrug Capecitabine are widely used in the treatment of several solid tumors (gastro-intestinal, gynecological, head and neck, breast carcinomas). Therapy with fluoropyrimidines is associated with a wide range of adverse effects, including diarrhea, dehydration, abdominal pain, nausea, stomatitis, and hand-foot syndrome. Among the 5-FU side effects, increasing attention is given to cardiovascular toxicities induced at different levels and intensities. Since the mechanisms related to 5-FU-induced cardiotoxicity are still unclear, we examined the effects of 5-FU on primary cell cultures of human cardiomyocytes and endothelial cells, which represent two key components of the cardiovascular system. We analyzed at the cellular and molecular level 5-FU effects on cell proliferation, cell cycle, survival and induction of apoptosis, in an experimental cardioncology approach. We observed autophagic features at the ultrastructural and molecular levels, in particular in 5-FU exposed cardiomyocytes. Reactive oxygen species (ROS) elevation characterized the endothelial response. These responses were prevented by a ROS scavenger. We found induction of a senescent phenotype on both cell types treated with 5-FU. In vivo, in a xenograft model of colon cancer, we showed that 5-FU treatment induced ultrastructural changes in the endothelium of various organs. Taken together, our data suggest that 5-FU can affect, both at the cellular and molecular levels, two key cell types of the cardiovascular system, potentially explaining some manifestations of 5-FU-induced cardiovascular toxicity.

In Vitro Study

Rigorous Journal

Highly Cited

Study Snapshot

5-Fluorouracil can affect key cardiovascular system cells, potentially explaining some manifestations of its cardiovascular toxicity.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes

Sign up to use Study Snapshot

References

A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine

5-Fluorouracil (5-FU) and capecitabine (5-C) both cause cardiac toxicity through oxidative stress and mitochondrial dysfunction, leading to caspase-3 activation and cell death in heart cardiomyocytes.

Reactive Oxygen Species

Reactive oxygen species (ROS) play diverse roles in chronic diseases, environmental effects, and signaling, with some contributing to oxidative stress and others playing homeostatic functions.

A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives.

5-fluorouracil can induce cardiotoxicity through oxidative stress, and strategies based on scavengers could help prevent this effect.

Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells.

Cell-cycle perturbation or elevated Thymidilate Synthase protein expression may contribute to acquired 5-FU resistance in head and neck carcinoma cells, identifying resistance mechanisms in different treatment regimens.

A drug-induced accelerated senescence (DIAS) is a possibility to study aging in time lapse

Mitomycin C treatment induces long-term accelerated senescence in human dermal fibroblasts, demonstrating that a combination of reactive oxygen species and DNA alkylation is necessary to induce a permanent senescent cell type.

Mitochondrial oxidative stress in aging and healthspan

Mitochondrial oxidative stress contributes to aging and healthspan, with potential therapeutic strategies focusing on mitochondrial protective drugs like MitoQ, SkQ1, and SS-31.

Cellular senescence in ageing, age-related disease and longevity.

Modulating cellular senescence may be a potential pro-longevity strategy, as it contributes to ageing and age-related diseases by generating low-grade inflammation and potentially stimulating cancer development.

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors.

Symptomatic cardiotoxicity occurs in 1.2-4.43% of patients treated with fluorouracil, but subclinical cardiac influence is common, with potential risk factors including cardiac co-morbidity, continuous infusion schedules, and concomitant cisplatin treatment.

Age-associated stresses induce an anti-inflammatory senescent phenotype in endothelial cells

Age-associated stresses, such as oxidative stress, disturbed flow, and hypoxia, induce senescence in endothelial cells, leading to an anti-inflammatory phenotype, potentially playing a protective role against cardiovascular disease.

Citations